NSBCC: NanoSystems Biology Cancer Center - Strategic Partnerships

CCNE Alliance Bulletin

Fri, 12 Sep 2008 11:34:57 -0700

The CCNE Alliance Bulletin for Summer, 2008 is now available!

PETNET Solutions

Mon, 23 Jan 2006 10:25:18 -0800

PETNET® Pharmaceuticals, Inc., headquartered in Knoxville, Tennessee, is the nation's leading provider of molecular tracers for PET imaging. PETNET® offers the only cyclotron-based nationwide network of radiopharmacies that produce and distribute MetaTrace FDG® and other probes to hospitals, clinics, and provider centers.

Liquidia Technologies

Mon, 23 Jan 2006 10:09:53 -0800

Liquidia Technologies provides an enabling material platform: innovative fluoropolymers that are liquids at room temperature, but cure to crystal clear "PTFE-like" elastic solids when exposed to light for a few minutes. The resulting material combines the appealing properties of silicone elastomers and glass – outperforming each, individually – and makes revolutionary applications possible. Liquidia's products will be solvent- and chemically resistant microfluidics and high performance imprint lithographic materials and processes.

Homestead Clinical Corporation

Thu, 19 Jan 2006 11:02:35 -0800

Homestead was founded to commercialize a suite of technologies developed at the Institute for Systems Biology (ISB) that have broad utility in the development of novel diagnostic tools. The ISB is a world-renowned non- profit research institute whose mission is to unravel the mysteries of diseases such as cancer, diabetes and AIDS. Homestead will utilize proprietary technologies, licensed from the ISB, to develop diagnostic tools, designed to facilitate early intervention in a variety of diseases.

Materia

Thu, 19 Jan 2006 10:25:25 -0800

Materia Incorporated is a leader in developing and commercializing solutions to complex problems in Life Sciences, Polymers and Materials Science, and Chemical Manufacturing. The company practices innovative and proprietary Metathesis and Organocatalysis™ Technologies to provide sustainable cost advantages in the production of small, medium, and large molecules while simultaneously enabling previously unattainable features, qualities, and substances to be obtained.